Dr. Daniel Gould Discusses GLP-1 Weight Loss and 2025 Plastic Surgery Trends with NewBeauty

Beverly Hills plastic and reconstructive surgeon Dr. Daniel Gould was featured in NewBeauty as part of its forecast of the plastic surgery and aesthetic trends expected to shape 2025. The article brings together perspectives from leading surgeons on evolving facial procedures, regenerative aesthetics, body contouring, breast surgery, and the growing influence of GLP-1 medications on aesthetic treatment.

One of the major trends identified for 2025 is the increasing number of patients seeking aesthetic procedures after significant weight loss. Medications such as semaglutide have transformed the weight-loss landscape, but substantial changes in body composition can also create new aesthetic concerns, including skin laxity and loss of facial volume.

Dr. Gould highlighted an important distinction between facial changes associated with significant weight loss and those caused by the traditional aging process. While both can involve changes in volume and skin laxity, rapid or substantial weight loss can affect facial fat and underlying tissues in ways that require different considerations when evaluating a patient for facial rejuvenation.

This distinction becomes particularly important when planning procedures such as facelifts. Rather than approaching every patient with facial laxity in the same way, surgeons need to understand how changes in muscle, fat, skin, and overall facial volume have contributed to the patient's appearance. Dr. Gould emphasized the need for surgeons to recognize these differences when treating patients who have experienced significant GLP-1-related weight loss.

The trend reflects a broader movement toward increasingly individualized plastic surgery. As new medications and changes in patient lifestyles influence anatomy in different ways, treatment planning must evolve alongside them. The appropriate procedure depends not only on what a patient would like to address, but also on the structural and biological changes responsible for those concerns.

The NewBeauty feature also explores several other developments expected to influence aesthetic medicine in 2025, including subtle facial enhancements, longer-term approaches to facial rejuvenation, regenerative techniques, post-weight-loss body contouring, and growing interest in natural-looking results.

Dr. Gould’s perspective underscores how the rise of GLP-1 medications is changing more than the demand for plastic surgery. It is also creating a new set of anatomical considerations for surgeons, reinforcing the importance of understanding the underlying cause of facial changes before determining the appropriate surgical approach.